PRKG2: A Protein Involved in Brain Signaling Pathways (G5593)

Target Name: PRKG2

NCBI ID: G5593

PRKG2

PRKG2: A Protein Involved in Brain Signaling Pathways

PRKG2, also known as PRKG2 variant 1, is a protein that is expressed in the brain and plays a critical role in the regulation of cell signaling pathways. The protein is a key component of the protein complex known as the PRKG2 complex, which is involved in the regulation of a wide range of cellular processes, including cell signaling, cytoskeletal organization, and neurotransmitter release.

Recent studies have identified PRKG2 as a potential drug target for a variety of psychiatric and neurological disorders, including depression, anxiety, and schizophrenia. This is because the PRKG2 complex is involved in the regulation of many key signaling pathways that are implicated in the development and maintenance of these disorders.

One of the key mechanisms by which PRKG2 is involved in the regulation of cellular signaling pathways is through its role as a negative regulator of the protein kinase A (PKA). PKA is a well-known enzyme that is involved in the regulation of many cellular processes, including cell signaling, DNA replication, and neurotransmitter release. PRKG2 is known to play a negative role in the regulation of PKA, by interacting with it and inhibiting its activity.

This interaction between PRKG2 and PKA is important because PKA is often overexpressed in many psychiatric and neurological disorders, including depression and anxiety. By inhibiting the activity of PKA, PRKG2 may help to reduce the activity of this enzyme and decrease the risk of the disorders.

Another mechanism by which PRKG2 is involved in the regulation of cellular signaling pathways is through its role as a positive regulator of the protein kinase CK (CK). CK is a well-known enzyme that is involved in the regulation of muscle contractions and cell signaling pathways. PRKG2 is known to play a positive role in the regulation of CK, by interacting with it and increasing its activity.

This interaction between PRKG2 and CK is important because CK is often overexpressed in many psychiatric and neurological disorders, including muscle rigidity and several neurodegenerative diseases. By increasing the activity of CK, PRKG2 may help to reduce the activity of this enzyme and decrease the risk of the disorders.

In addition to its role as a negative and positive regulator of PKA and CK, PRKG2 is also involved in the regulation of many other cellular signaling pathways. For example, PRKG2 is known to play a role in the regulation of the protein kinase B (BK ), which is involved in the regulation of DNA replication and cell signaling pathways. PRKG2 is also involved in the regulation of the protein kinase D (PKD), which is involved in the regulation of neurotransmitter release and pain signaling.

Overall, PRKG2 is a protein that is involved in the regulation of many cellular signaling pathways and is a potential drug target for a variety of psychiatric and neurological disorders. Further research is needed to fully understand the role of PRKG2 in the regulation of cellular signaling pathways and its potential as a drug target.

Protein Name: Protein Kinase CGMP-dependent 2

Functions: Crucial regulator of intestinal secretion and bone growth. Phosphorylates and activates CFTR on the plasma membrane. Plays a key role in intestinal secretion by regulating cGMP-dependent translocation of CFTR in jejunum (PubMed:33106379). Acts downstream of NMDAR to activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By similarity). Acts as regulator of gene expression and activator of the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2 in mechanically stimulated osteoblasts. Under fluid shear stress, mediates ERK activation and subsequent induction of FOS, FOSL1/FRA1, FOSL2/FRA2 and FOSB that play a key role in the osteoblast anabolic response to mechanical stimulation (By similarity)

The "PRKG2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRKG2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets